Metabolic syndrome (MetS) describes a cluster of cardio-metabolic factors that predispose to
type 2 diabetes mellitus (T2DM) and atherosclerotic cardiovascular disease (ASCVD). While …

Accumulating evidence indicates that obesity is closely associated with an increased risk of
metabolic diseases such as insulin resistance, type 2 diabetes, dyslipidemia and …

The worldwide epidemic of obesity has brought considerable attention to research aimed at
understanding the biology of adipocytes (fat cells) and the events occurring in adipose …

Obesity is associated with an array of health problems in adult and pediatric populations.
Understanding the pathogenesis of obesity and its metabolic sequelae has advanced …

Background. It has been suggested that visfatin, which is an adipocytokine, exhibits
proinflammatory properties and is associated with insulin resistance. Insulin resistance and …

Endothelium is the largest organ in the body strategically located between the wall of blood
vessels and the blood stream. The human body contains approximately 1013 endothelial …

Adipose tissue is acknowledged as an endocrine organ that releases bioactive factors
termed adipokines. Visfatin was initially identified as a novel adipokine with insulin‐mimetic …

The growing worldwide burden of insulin resistance (IR) emphasizes the importance of early
identification for improved management. Obesity, particularly visceral obesity, has been a …

The prevalence of type 2 diabetes (T2D) is rapidly increasing. This is strongly related to the
contemporary lifestyle changes that have resulted in increased rates of overweight …

Objectives Visfatin is a new cytokine that act as an insulin analogue on the insulin receptor
and may link obesity and insulin resistance. It was recently shown that visfatin plays a role in …